BPC-157 / TB-500 Capsules

BPC-157/TB-500 Capsules Research Overview
BPC-157/TB-500 Capsules are a high-purity, research-grade blend containing BPC-157 and TB-500 designed exclusively for laboratory investigation of tissue repair, regeneration, angiogenesis, and wound healing. Each capsule delivers defined amounts of the two peptides (250 mcg BPC-157 and 250 mcg TB-500). BPC-157/TB-500 Capsules are intended solely for research purposes.

Molecular Composition and Mechanistic Profile

• BPC-157 (Body Protection Compound-157): A synthetic pentadecapeptide (sequence GEPPPGKPADDAGLV, molecular formula C₆₂H₉₈N₁₆O₂₂). It is studied in preclinical models for its effects on angiogenesis, fibroblast activity, collagen organization, and tissue protection.

• TB-500 (Thymosin Beta-4 fragment): A synthetic heptapeptide (sequence Ac-LKKTETQ, molecular formula C₃₈H₆₈N₁₀O₁₄). It is examined in research for roles in actin sequestration, cell migration, endothelial proliferation, and angiogenesis in wound healing models.

Experimental observations indicate that the combination allows investigation of complementary pathways in tissue regeneration, including vascular growth, fibroblast recruitment, matrix reorganization, and cellular protection. All work with BPC-157/TB-500 Capsules is for research purposes only.

Integrated Research Applications

• BPC-157/TB-500 Capsules are used in research to examine multi-component effects on tissue biology and repair. Typical research areas include:

• In vitro studies using fibroblast, endothelial, or epithelial cell models to measure migration, proliferation, collagen deposition, and responses to injury or oxidative stress.

• Ex vivo tissue constructs to assess wound closure kinetics, angiogenesis, and matrix remodeling under controlled peptide exposure.

• In vivo preclinical models investigating musculoskeletal injury, dermal repair, gastrointestinal integrity, or inflammatory conditions through pathways involving angiogenesis, ECM turnover, and cellular protection.

Using a single characterized capsule preparation allows consistent evaluation of combined peptide effects in research settings without variability from separate or undefined mixtures. BPC-157/TB-500 Capsules are intended for research use only.

Analytical Validation and Quality Assurance
Research grade BPC-157/TB-500 Capsules are manufactured with each peptide at high purity (typically ≥98–99%) and verified by high-performance liquid chromatography (HPLC) and mass spectrometry (MS).
Capsules are provided in sealed containers with labeling that documents exact peptide amounts per capsule (250 mcg BPC-157 / 250 mcg TB-500), while batch details, and research use disclaimers can be found on this store page. This format supports standardized dosing across experiments.

Storage and Stability Guidelines
Correct storage helps maintain the integrity of the peptides in BPC-157/TB-500 Capsules for reproducible results. Recommended conditions are:

• Room temperature (unopened capsules): Suitable for short periods when kept sealed, dry, and protected from light.

• Refrigerated storage (2–8 °C): Appropriate for unopened or opened containers intended for use within days to weeks.

• Frozen storage (≤ −20 °C): Preferred for long-term storage, with containers sealed to prevent moisture uptake and degradation.

Opened capsules or prepared solutions should be kept cold, protected from light, and used promptly according to standard laboratory practices.

BPC-157/TB-500 Capsules offered by NextGenPeps are intended solely for research use in vitro or in non-human in vivo studies. They may be incorporated into experimental designs focused on tissue repair or regenerative biology. They are provided strictly for research purposes only and must not be used outside approved laboratory protocols.